Market Cap (In CNY)
7.53 Billion
Revenue (In CNY)
816.76 Million
Net Income (In CNY)
253.9 Million
Avg. Volume
5.81 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.757142-9.535714
- PE
- -
- EPS
- -
- Beta Value
- -0.048
- ISIN
- CNE100002XK2
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Zhiguo Zheng
- Employee Count
- -
- Website
- https://www.ausunpharm.com
- Ipo Date
- 2017-05-09
- Details
- Zhejiang Ausun Pharmaceutical Co., Ltd. develops, produces, and sells specialty drug substances and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it is involved in the processing, and research and development business. The company was founded in 2010 is based in Linhai, China.
More Stocks
-
HR-UN
-
BMXCBemax Inc.
BMXC
-
GIGAGigante Salmon AS
GIGA
-
000750Sealand Securities Co., Ltd.
000750
-
1384Hokuryo Co., Ltd.
1384
-
000807Yunnan Aluminium Co., Ltd.
000807
-
ALDVFKiplin Metals Inc.
ALDVF
-
601878